1 |
Inoue I, Takahashi K, Noji S, Awata T, Negishi K, Katayama S. 1997. Acarbose controls postprandial hyperproinsulinemia in non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 36: 143-151
DOI
ScienceOn
|
2 |
Bastyr EJ, Stuart CA, Brodows RG, Schwartz S, Graf CJ, Zagar A, Robertson KE (IOEZ Study Group). 2000. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. Diabetes Care 23: 1236-1241
DOI
ScienceOn
|
3 |
Toeller M. 1994. -Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects. Eur J Clin Invest 24: 31-35
DOI
|
4 |
Kim JS, Kwon JS, Son KH, Kim JI. 2000. Alpha-glucosidase inhibitory activities of some wild vegetable extracts. J Food Sci Nutr 5: 174-176
과학기술학회마을
|
5 |
Avignon A, Radauceanu A, Monnier L. 1997. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20: 1822-1826
DOI
ScienceOn
|
6 |
Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA. 2000. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321: 405-412
DOI
ScienceOn
|
7 |
UK Prospective Diabetes Study (UKPDS) Group. 1998. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317: 703-713
DOI
ScienceOn
|
8 |
Abrahaamson MJ. 2004. Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context. Arch Intern Med 164: 486-491
DOI
ScienceOn
|
9 |
Lee DS, Lee SH. 2001. Genistein, a soy isoflavone, is a potent alpha glucosidase inhibitor. FEBS Lett 501: 84-86
DOI
ScienceOn
|
10 |
Wang YC, Yu RC, Chou CC. 2006. Antioxidative activities of soymilk fermented with lactic acid bacteria and bifidobacteria. Food Microbiol 23: 128-135
DOI
ScienceOn
|
11 |
Veciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, Evans AT. 1995. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 333: 1237-1241
DOI
ScienceOn
|
12 |
Watanabe J, Kawabata J, Kurihara H, Niki R. 1997. Isolation and identification of alpha-glucosidase inhibitors from Tochucha (Eucommia ulmoides). Biosic Biotechnol Biochem 61: 177-178
DOI
ScienceOn
|
13 |
Kim JS. 2004. Effect of Rhemanniae Radix on the hyperglycemic mice induced with streptozotocin. J Korean Soc Food Sci Nutr 33: 1133-1138
과학기술학회마을
DOI
ScienceOn
|
14 |
Saito N, Sakai H, Sekihara H, Yajima Y. 1998. Effect of an -glucosidase inhibitor (voglibose), in combination with sulphonilureas, on glycemic control in type 2 diabetes patients. J Int Med Res 26: 219-232
DOI
|
15 |
Coniff RF, Shapiro JA, Robbins D, Kleinfield R, Scaton TB, Beisswenger P, McGill JB. 1995. Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. Diabetes Care 18: 817-824
DOI
ScienceOn
|
16 |
Lebovitz HE. 1998. Postprandial hyperglycemic state: importance and consequences. Diabetes Res Clin Pract 40: S27-S28
DOI
ScienceOn
|
17 |
Li Y, Wen S, Kota BP, Peng G, Li GQ, Yamahara J, Roufogalis BD. 2005. Punica granatum flower extract, a potent -glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats. J Ethnopharmacol 99: 239-244
DOI
ScienceOn
|
18 |
Savitry A, Prakash M. 2004. Sing a song of soy. Prepared Food 4: 25-28
|
19 |
Ratner RE. 2001. Controlling postprandial hyperglycemia. Am J Cardiol 88: 26H-31H
DOI
ScienceOn
|
20 |
Baron AD. 1998. Postprandial hyperglycemia and -glucosidase inhibitors. Diabetes Res Clin Pract 40: S51-S55
DOI
ScienceOn
|
21 |
Soonthompun S, Rattarasarn C, Leelawattana R, Setasuban W. 1999. Postprandial plasma glucose: a good index of glycemic control in type 2 diabetic patients having nearnormal fasting glucose levels. Diabetes Res Clin Pract 46: 23-27
DOI
ScienceOn
|
22 |
Campbell RK, White JR, Nomura D. 2001. The clinical importance of postprandial hyperglycemia. Diabetes Educ 27: 624-637
DOI
|
23 |
Lebovitz HE. 2001. Effect of the postprandial state on nontraditional risk factors. Am J Cardiol 88: 20H-25H
DOI
ScienceOn
|
24 |
Corry DB, Tuck ML. 2000. Protection from vascular risk in diabetic hypertension. Curr Hypertens Rep 2: 154-159
DOI
ScienceOn
|
25 |
Holman RR, Cull CA, Turner RC. 1999. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (UK Prospective Diabetes Study 44). Diabetes Care 22: 960-964
DOI
ScienceOn
|
26 |
Clissold SP, Edwards C. 1988. A preliminary review of its pharmacodynamic and pharmacokinetics properties, and therapeutic potential. Drugs 35: 214-243
DOI
ScienceOn
|
27 |
Jermendy G. 2005. Can type 2 diabetes mellitus be considered preventable? Diabetes Res Clin Prac 68: S73-S81
DOI
ScienceOn
|
28 |
Asano N, Yamashita T, Yasuda K, Ikeda K, Kizu H, Kameda Y. 2001. Polyhydroxylated alkaloids isolated from mulberry trees (Morusalba L.) and silkworms (Bombyx mori L.). J Agric Food Chem 49: 4208-4213
DOI
ScienceOn
|
29 |
Hiroyuki F, Tomohide Y, Kazunori O. 2001. Efficacy and safety of Touchi extract, an alpha-glucosidase inhibitor derived from fermented soybeans, in non-insulin-dependent diabetic mellitus. J Nutr Biochem 12: 351-356
DOI
ScienceOn
|
30 |
Hansawasdic C, Kawabata J, Kasai T. 2000. -Amylase inhibitors from roselle (Hibiscus sabdariffa Linn.) tea. Biosci Biotechnol Biochem 64: 1041-1043
DOI
ScienceOn
|
31 |
Hanefeld M. 1998. The role of acarbose in the treatment of non-insulin-dependent diabetes mellitus. J Diabetes Complicat 12: 228-237
DOI
ScienceOn
|
32 |
Anderson JW, Johnstone BM, Cook N. 1995. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333: 276-282
DOI
ScienceOn
|
33 |
Potter SM. 1998. Soy protein and cardiovascular disease: the impact of bioactive components in soy. Nutr Rev 56: 231-235
|
34 |
Anderson JB, Anthony M, Messina M, Garner SC. 1999. Effects of phyto-estrogens on tissues. Nutr Res Rev 12: 75-116
DOI
|
35 |
Bingham SA, Atkinson C, Liggins J, Bluck L, Coward A. 1998. Phyto-estrogens: where are we now? Br J Nutr 79: 393-406
DOI
ScienceOn
|
36 |
Setchell KDR, Cassidy A. 1999. Dietary isoflavones: biological effects and relevance to human health. J Nutr 129: 758S-767S
DOI
|
37 |
Kuo LC, Cheng WY, Wu RY, Huang CJ, Lee KT. 2006. Hydrolysis of black soybean isoflavone glycosides by Bacillus subtilis natto. Appl Microbiol Biotechnol 73: 314-320
DOI
ScienceOn
|
38 |
Lebovitz HE. 1997. Alpha-glucosidase inhibitors. Endocrin Metab Clin 26: 539-551
DOI
|
39 |
Hara Y, Honda M. 1990. The inhibition of -amylase by tea polyphenols. Agric Biol Chem 54: 1939-1945
DOI
|
40 |
The Diabetes Control and Complications Trial (DCCT) Research Group. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in the diabetes control in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986
DOI
ScienceOn
|
41 |
Balflour JA, McTavish D. 1993. Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitus. Drugs 46: 1025-1054
DOI
ScienceOn
|
42 |
Standl E, Baumgartl HJ, Fuchtenbusch M, Stemplinger J. 1999. Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy. Diabetes Obes Metab 1: 215-220
DOI
ScienceOn
|
43 |
Matsui T, Ueda T, Oki T, Sugita K, Terahara N, Matsumoto K. 2001. Alpha-glucosidase inhibitory action of natural acylated anthocyanins. 1. Survey of natural pigments with potent inhibitory activity. J Agric Food Chem 49: 1948-1951
DOI
ScienceOn
|
44 |
Hermansen K, Sondergaard M, Hoie L, Carstensen M, Brock B. 2001. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 24: 228-233
DOI
ScienceOn
|
45 |
Rebeca FO, Juana F, Rosario M, Henryk Z, Mariusz KP, Halina K, Concepcion V. 2007. Fermentation as a bio process to obtain functional soybean flours. J Agric Food Chem 55: 8872-8979
DOI
ScienceOn
|